FindTrial
Sign In

Construction of a self-management model for symptom burden in patients treated with pharmacological depot therapy for breast cancer

Construction of a self-management model for symptom burden in patients treated with pharmacological depot therapy for breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084753
Enrollment
Unknown
Registered
2024-05-23
Start date
2024-05-30
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

BREAST CANCER

Interventions

intervention group:self-help care
control group:routine care

Sponsors

Ruijin Hospital, Shanghai Jiao Tong University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Signed and dated informed consent form Commitment to comply with the study procedures and co-operate with the implementation of the full course of the study First diagnosis of breast cancer 2-3 weeks after diagnosis, the multidisciplinary consultation protocol specifies acceptance of debulking treatment

Exclusion criteria

Exclusion criteria: Persons with a combination of severe impairment of the function of other vital organs; Those with cognitive dysfunction or various types of psychiatric disorders; Those who present with distant metastasis or recurrent malignant tumour lesions; Those who are uninformed about their condition.

Design outcomes

Primary

MeasureTime frame
symptom burden;—

Secondary

MeasureTime frame
Quality of life;—

Countries

China

Contacts

Public ContactChen Yunyun

Department of Nursing, Ruijin Hospital, Shanghai Jiao Tong University

cyy21932@rjh.com.cn+86 137 6173 2392

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026